Nike Now Yields More Than Coca-Cola. Is the Turnaround Finally Priced In?

Source Motley_fool

Key Points

  • Nike’s ~4% forward yield suggests the stock could be undervalued and due for a rebound as the turnaround progresses.

  • The payout ratio is elevated but Nike could see a rebound in profitability over the next year, helping support the dividend.

  • Nike's price-to-sales multiple could get rerated higher if continues to improve inventory management, sales mix, and margins.

  • 10 stocks we like better than Nike ›

Nike's (NYSE: NKE) forward (12-month) dividend yield is 4% -- well above Coca-Cola's 2.4%. This is notable given Coke's status as a Dividend King, a label reserved for companies that have raised their dividends for 50-plus straight years.

Nike's elevated yield reflects a lower share price despite the company continuing to pay a steady quarterly dividend. Instead of being priced in, the market might be undervaluing the stock ahead of a successful turnaround.

Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a "Double Down" signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same "Total Conviction" signal is flashing for a company 1/100th the size of Nvidia. Continue »

Nike's latest results still showed revenue declines, yet the underlying story is getting more constructive. If management executes, an improvement in margins and recovery in profitability could drive meaningful upside over the next several years.

Nike logo

Image source: The Motley Fool.

Why Nike's dividend looks sustainable

High yields often show up when investors expect limited growth -- which is why mature, dominant businesses with less runway, including many Dividend Kings, tend to pay above-average yields. Those stocks are typically bought for income first, not for market-beating appreciation.

Nike's yield is high mainly because the stock is down, not because the company can't afford the payout. The company recently declared a $0.41 dividend, payable Oct. 1 to shareholders of record Sept. 1, putting the annualized dividend at $1.64 per share.

Although the payout ratio is elevated, Nike still generates sufficient cash to support its quarterly dividend, especially given the expected rebound in fiscal 2027. Nike's trailing 12-month free cash flow of $2.2 billion was less than its $2.4 billion in dividend distributions over the same period. But analysts expect free cash flow to rebound to $3 billion in fiscal 2027, consistent with positive trends management is beginning to see in margin stabilization.

If cash generation improves as management focuses on cleaning up inventory, the dividend becomes easier to support -- and the stock has room to move higher. Unlike Coke, Nike can offer both income and real upside.

Why Nike's turnaround is hitting an inflection point

Full-year sales were essentially flat at about $46 billion (down 2% on a currency-neutral basis). Still, Nike's latest earnings report included signals of improving fundamentals.

Demand remains softest in lifestyle categories (sportswear and Jordan streetwear), which still represent roughly half of sales. But performance wear is holding up better -- and that matters because it's the core of Nike's brand.

Nike Running is the standout, producing five straight quarters of double-digit growth. Management also pointed to better retail trends in training and global football. Strength in these categories suggests Nike is winning where it historically wins best -- performance products -- and that healthier growth can return as the company fixes inventory levels and leans harder into its strongest franchises.

Valuation helps the investment case. Nike trades at about 1.3x sales, well below its historical norm of 2.0x or higher. If Nike cleans up inventory, improves sales mix, and expands margins, investors could reward it with a higher multiple.

The turnaround path will likely stay bumpy in a cautious consumer environment. But between the high yield and the discounted price-to-sales ratio, the market doesn't appear to be fully pricing in a successful turnaround -- and that could offer investors meaningful upside potential.

Should you buy stock in Nike right now?

Before you buy stock in Nike, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Nike wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $432,189!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,330,956!*

Now, it’s worth noting Stock Advisor’s total average return is 967% — a market-crushing outperformance compared to 212% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.

See the 10 stocks »

*Stock Advisor returns as of August 22, 2026.

John Ballard has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Nike. The Motley Fool has a disclosure policy.

Disclaimer: For information purposes only. Past performance is not indicative of future results.
placeholder
Elon Musk’s AI Startup Acquisition Fails to Land as Cognition Rebuffs SpaceX BuyoutSpaceX’s attempt to acquire artificial intelligence coding startup Cognition AI Inc. stalled without a deal, according to people familiar with the matter. The approach would have been SpaceX’s second
Author  Beincrypto
Aug 20, Thu
SpaceX’s attempt to acquire artificial intelligence coding startup Cognition AI Inc. stalled without a deal, according to people familiar with the matter. The approach would have been SpaceX’s second
placeholder
Eli Lilly Price Forecast: The Next Big Stock After Weight-Loss Drug Breakthrough?Eli Lilly is one of the most popular names today in America’s weight-loss and diabetes drug market. Its drugs delivered an average weight loss of 28.3% in a Phase 3 trial, approaching results historic
Author  Beincrypto
Aug 20, Thu
Eli Lilly is one of the most popular names today in America’s weight-loss and diabetes drug market. Its drugs delivered an average weight loss of 28.3% in a Phase 3 trial, approaching results historic
placeholder
MicroStrategy Erases 2-Month Loss as Crypto Stocks Rally: Is the Damage Over?Strategy, the company once called MicroStrategy (MSTR), rose 6.9% to $111.14 on Thursday afternoon. That is its best price since June 18, which wipes out a two-month slide.The stock market has forgive
Author  Beincrypto
Yesterday 01: 47
Strategy, the company once called MicroStrategy (MSTR), rose 6.9% to $111.14 on Thursday afternoon. That is its best price since June 18, which wipes out a two-month slide.The stock market has forgive
placeholder
Anthropic IPO May Top SpaceX Record: Will It Raise $100 Billion?Anthropic expects its stock market debut to match or beat the largest listing in history, according to people familiar with the matter. The bar is SpaceX, and it sits at $85.7 billion.The Claude devel
Author  Beincrypto
Yesterday 01: 48
Anthropic expects its stock market debut to match or beat the largest listing in history, according to people familiar with the matter. The bar is SpaceX, and it sits at $85.7 billion.The Claude devel
placeholder
$248 Million Mutual Fund Invests in Ripple. Does It Matter for XRP?Kinetics Internet Portfolio, a mutual fund with $248 million in assets, disclosed a direct equity stake in Ripple Labs itself rather than in XRP, according to a newly filed SEC report.The distinction
Author  Beincrypto
Yesterday 01: 50
Kinetics Internet Portfolio, a mutual fund with $248 million in assets, disclosed a direct equity stake in Ripple Labs itself rather than in XRP, according to a newly filed SEC report.The distinction
goTop
quote